Platelet protection solution having beta-galactosidase and sialidase inhibitors
US9788539B2 · kind B2 · utility
1Cited by
67References
25Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 2, 2016 |
| Grant date | Oct 17, 2017 |
| Priority date | — |
| Expiry date | Feb 2, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01N1/126
- WIPO fieldBasic materials chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to a platelet protection solution (PPS) having an amount of one or more β-galactosidase inhibitors with or without an amount of one or more sialidase inhibitors, and optionally one or more glycan-modifying agents; and one or more of PPS components that include a salt, a citrate source, a carbon source, or any combination thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.